Coloplast A/S reported a strong FY 2024/25 with 7% organic growth and an EBIT margin of 28%. Revenue increased to DKK 27,874 million, with growth across all business areas. The company also saw a 5% increase in EBIT and a 2% increase in adjusted net profit. Sustainability highlights include increased production waste recycling and a 41% decrease in emissions. FY 2025/26 guidance predicts around 7% organic revenue growth and 7% EBIT growth, with a focus on Chronic Care and Acute Care. The company plans to continue improving efficiency and investing in new strategies.

Coloplast A/S, known for creating the world’s first adhesive ostomy bag in 1954, continues to develop products that help millions live more independently. The company’s global business areas include Ostomy Care, Continence Care, Voice & Respiratory Care, Wound & Tissue Repair, and Interventional Urology. Coloplast’s commitment to innovation and sustainability drives its success in providing solutions tailored to individual needs. For more information, visit their website or contact their Investor Relations or Media Relations teams for inquiries.

Read more at GlobeNewswire: Coloplast A/S – Annual Report 2024/25 & Remuneration Report